Choice of planes for sector dosimetric analysis for implant quality assurance in permanent prostate brachytherapy

被引：0
|
作者：
Mitchell, D. [1 ]
Yoosuf, A. B. M. [2 ]
Byrne, M. [2 ]
Flynn, M. [2 ]
Napier, E. [3 ]
Workman, G. [2 ]
Jain, S. [1 ]
机构：
[1] Northern Ireland Canc Ctr, Clin Oncol, Belfast, Antrim, North Ireland
[2] Northern Ireland Canc Ctr, Med Phys, Belfast, Antrim, North Ireland
[3] Northern Ireland Canc Ctr, Radiol, Belfast, Antrim, North Ireland
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1938
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [1] DOSIMETRIC EVALUATION AT 01 AND 030 FOR PERMANENT IMPLANT BRACHYTHERAPY IN PROSTATE CANCER
    Horn, S.
    Lacornerie, T.
    Cheval, V.
    Bonodeau, F.
    Nickers, P.
    Lartigau, E.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S212 - S212
  • [2] The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis
    Nag, S
    Bice, W
    DeWyngaery, K
    Prestidge, B
    Stock, R
    Yu, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (01): : 221 - 230
  • [3] Preimplant dosimetric parameters as predictors of postimplant quality in permanent prostate brachytherapy
    Butler, W
    Merrick, G
    Allen, Z
    MEDICAL PHYSICS, 2003, 30 (06) : 1430 - 1430
  • [4] Predictive factors for post-implant dosimetric outcomes in transperineal permanent prostate brachytherapy
    Meier, R
    Grimm, PD
    Sylvester, JE
    Blasko, JC
    RADIOLOGY, 2002, 225 : 266 - 266
  • [5] OPTIMIZATION VS NON-OPTIMIZED BRACHYTHERAPY FOR PERMANENT IMPLANT PROSTATE: DOSIMETRIC RESULTS
    Chemin, A.
    Thomas, L.
    Torruco, B. Santamaria
    Behomme, S.
    Lasbareilles, O.
    Valton, M.
    Richaud, R.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S44 - S44
  • [6] Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations
    Haidari, Ali-Reza Mehan
    Miksys, Nelson
    Soubiran, Paul
    Cygler, Joanna Ewa
    Holmes, Oliver
    Perry, Gad
    Thomson, Rowan M.
    BRACHYTHERAPY, 2019, 18 (06) : 875 - 882
  • [7] Dosimetric guidance on using brachytherapy (LDR or HDR) to offset a flawed permanent prostate implant
    Zaider, M.
    MEDICAL PHYSICS, 2007, 34 (06) : 2442 - 2442
  • [8] QUALITY ASSURANCE FOR PROSTATE BRACHYTHERAPY
    AI-Qaisieh, B.
    Baltas, D.
    Hellebust, T. P.
    Siebert, F. A.
    Kirisits, C.
    Venselaar, J.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S40 - S40
  • [9] Permanent implant prostate cancer brachytherapy
    Cosset, J. -M.
    Flam, T.
    Thiounn, N.
    Pontvert, D.
    Pierrat, N.
    Vallancien, G.
    Chauvein, L.
    CANCER RADIOTHERAPIE, 2008, 12 (6-7): : 503 - 511
  • [10] Postimplant dosimetric assessment of transperineal interstitial permanent prostate brachytherapy: Improvement in quality of implant over time in a single institution
    Malkoske, K.
    Bews, J.
    Schroeder, G.
    Cho, P.
    Drachenberg, D.
    Chowdhury, A.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S32 - S32
12345